Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.

@article{Broch2012SolubleSI,
  title={Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.},
  author={Kaspar Broch and Thor Ueland and St{\aa}le Haugset Nymo and John K. Kjekshus and Johannes Hulthe and Pieter Muntendam and John J V McMurray and John Wikstrand and John George Franklin Cleland and P. A. Aukrust and Lars Gullestad},
  journal={European journal of heart failure},
  year={2012},
  volume={14 3},
  pages={
          268-77
        }
}
AIMS In patients with ischaemic heart failure (HF), myocardial dysfunction often progresses. Elevated levels of soluble ST2 (sST2) are associated with a poor prognosis, but an association between sST2 and worsening heart failure per se has not been established. We assessed the association between sST2 and cause-specific outcome in 1449 patients enrolled in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA study). METHODS AND RESULTS Soluble ST2 was measured with a… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 42 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Similar Papers

Loading similar papers…